Seizure, Alcohol Related Clinical Trial
Official title:
A Pilot Study Examining the Efficacy of Keppra in Acute Alcohol Related Seizure Control in the Emergency Department Setting
NCT number | NCT00627133 |
Other study ID # | K17644 |
Secondary ID | |
Status | Withdrawn |
Phase | Phase 2 |
First received | |
Last updated | |
Start date | February 2008 |
Verified date | February 2008 |
Source | Medical University of South Carolina |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | February 2008 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility |
Inclusion Criteria: - No trauma - Not pregnant - No other cause for seizure (hypoglycemia, CNS causes, trauma) - Good family support - Working telephone contact Exclusion Criteria: - Pregnancy - Renal failure (creatine > 2mg/dl - Fever or illness - Hypotension - Any trauma |
Country | Name | City | State |
---|---|---|---|
United States | Medical University of South Carolina | Charleston | South Carolina |
Lead Sponsor | Collaborator |
---|---|
Medical University of South Carolina | UCB Pharma |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Decreased seizures | 1, 2, 4, 8 weeks |